105 related articles for article (PubMed ID: 25175494)
1. Relapse of myeloid neoplasm with eosinophilia and PDGFRA rearrangement after imatinib discontinuation in a pediatric patient.
Rathe M; Schomerus E; Wehner PS; Kristensen TK; Møller MB
Pediatr Blood Cancer; 2014 Dec; 61(12):2328. PubMed ID: 25175494
[No Abstract] [Full Text] [Related]
2. Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate.
Rathe M; Kristensen TK; Møller MB; Carlsen NL
Pediatr Blood Cancer; 2010 Oct; 55(4):730-2. PubMed ID: 20589620
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive genomic profiling identifies a novel TNKS2-PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy.
Chalmers ZR; Ali SM; Ohgami RS; Campregher PV; Frampton GM; Yelensky R; Elvin JA; Palma NA; Erlich R; Vergilio JA; Chmielecki J; Ross JS; Stephens PJ; Hermann R; Miller VA; Miles CR
Blood Cancer J; 2015 Feb; 5(2):e278. PubMed ID: 25658984
[No Abstract] [Full Text] [Related]
4. Case of polycythemia vera concurrent with FIP1L1-PDGFRA-positive myeloproliferative neoplasm with eosinophilia.
Alrwas A; Quesada JR; Marcos LA; Mehta SS; Shattuck BL; Nguyen ND; Juneja HS
Cancer Genet; 2012 Oct; 205(10):519-22. PubMed ID: 22944561
[TBL] [Abstract][Full Text] [Related]
5. PDGFRA rearrangement leading to hyper-eosinophilia, T-lymphoblastic lymphoma, myeloproliferative neoplasm and precursor B-cell acute lymphoblastic leukemia.
Huang Q; Snyder DS; Chu P; Gaal KK; Chang KL; Weiss LM
Leukemia; 2011 Feb; 25(2):371-5. PubMed ID: 21304535
[No Abstract] [Full Text] [Related]
6. [Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1].
Fan XS; Wang SA
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):779-83. PubMed ID: 23302345
[No Abstract] [Full Text] [Related]
7. Complete response of myeloid sarcoma with FIP1L1-PDGFRA -associated myeloproliferative neoplasms to imatinib mesylate monotherapy.
Tang TC; Chang H; Chuang WY
Acta Haematol; 2012; 128(2):83-7. PubMed ID: 22722648
[TBL] [Abstract][Full Text] [Related]
8. Therapy-related acute myeloid leukemia with eosinophilia, basophilia, t(4;14)(q12;q24) and PDGFRA rearrangement: a case report and review of the literature.
Zhou J; Papenhausen P; Shao H
Int J Clin Exp Pathol; 2015; 8(5):5812-20. PubMed ID: 26191303
[TBL] [Abstract][Full Text] [Related]
9. A 32-year-old man with persistent cough, shortness of breath, eosinophilic pneumonia, and peripheral blood eosinophilia. Myeloid neoplasm associated with eosinophilia and platelet-derived growth factor receptor-alpha rearrangement.
Hossain NM; Jain N; Steinmetz JL; McConville JF; Anastasi J; Odenike O
Chest; 2012 Dec; 142(6):1680-1683. PubMed ID: 23208343
[No Abstract] [Full Text] [Related]
10. Congenital and childhood myeloproliferative disorders with eosinophilia responsive to imatinib.
Abraham S; Salama M; Hancock J; Jacobsen J; Fluchel M
Pediatr Blood Cancer; 2012 Nov; 59(5):928-9. PubMed ID: 22488677
[TBL] [Abstract][Full Text] [Related]
11. A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours.
Baruchel S; Sharp JR; Bartels U; Hukin J; Odame I; Portwine C; Strother D; Fryer C; Halton J; Egorin MJ; Reis RM; Martinho O; Stempak D; Hawkins C; Gammon J; Bouffet E
Eur J Cancer; 2009 Sep; 45(13):2352-9. PubMed ID: 19505817
[TBL] [Abstract][Full Text] [Related]
12. Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review.
Savage N; George TI; Gotlib J
Int J Lab Hematol; 2013 Oct; 35(5):491-500. PubMed ID: 23489324
[TBL] [Abstract][Full Text] [Related]
13. Atypical Phenotype and Treatment Response Pattern in a Patient with FIP1L1-PDGFRα Mutation.
Bikhchandani M; Johnson R; Tuan B; Tefferi A
Acta Haematol; 2018; 140(2):67-70. PubMed ID: 30184522
[TBL] [Abstract][Full Text] [Related]
14. Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma.
Metzgeroth G; Walz C; Score J; Siebert R; Schnittger S; Haferlach C; Popp H; Haferlach T; Erben P; Mix J; Müller MC; Beneke H; Müller L; Del Valle F; Aulitzky WE; Wittkowsky G; Schmitz N; Schulte C; Müller-Hermelink K; Hodges E; Whittaker SJ; Diecker F; Döhner H; Schuld P; Hehlmann R; Hochhaus A; Cross NC; Reiter A
Leukemia; 2007 Jun; 21(6):1183-8. PubMed ID: 17377585
[TBL] [Abstract][Full Text] [Related]
15. Concomitant eosinophilia, fasciitis, and mycosis fungoides-like reaction with antinuclear autoantibodies in chronic myeloid leukaemia: role of a T-cell clone induced by imatinib.
Jardin F; Courville P; Lenain P; Lenormand B; Pouplin S; Contentin N; Lehembre S; Laquerriere A; Clément JF; Tilly H
Lancet Oncol; 2005 Sep; 6(9):728-9. PubMed ID: 16129375
[No Abstract] [Full Text] [Related]
16. Philadelphia chromosome-negative myeloproliferative neoplasm with a novel platelet-derived growth factor receptor-β rearrangement responsive to imatinib.
Cornfield D; Shah U; Cross N; Bennett C; Sun G
J Clin Oncol; 2012 Mar; 30(9):e109-11. PubMed ID: 22331939
[No Abstract] [Full Text] [Related]
17. Fasting glucose level reduction induced by imatinib in chronic myeloproliferative disease with TEL-PDGFRβ rearrangement and type 1 diabetes.
Salaroli A; Loglisci G; Serrao A; Alimena G; Breccia M
Ann Hematol; 2012 Nov; 91(11):1823-4. PubMed ID: 22623162
[No Abstract] [Full Text] [Related]
18. Myeloid/lymphoid neoplasm associated with eosinophilia and concurrent rearrangement of PDGFRA and FGFR1: A very rare pediatric case.
Wang B; Wang X; Lin J; Zhang Y; Gan W; Li T
Pediatr Blood Cancer; 2023 Oct; 70(10):e30507. PubMed ID: 37336772
[No Abstract] [Full Text] [Related]
19. Imatinib induced pyoderma gangrenosum.
Pinato DJ; Sharma R
J Postgrad Med; 2013; 59(3):244-5. PubMed ID: 24029213
[No Abstract] [Full Text] [Related]
20. Spontaneous hemoperitoneum in recurrent jejunal gastrointestinal stromal tumor after imatinib therapy.
Yin TC; Fan WC; Huang CJ; Hsieh JS
Kaohsiung J Med Sci; 2013 Jul; 29(7):402-3. PubMed ID: 23768706
[No Abstract] [Full Text] [Related]
[Next] [New Search]
